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Abstract
The structure and dynamics of a double 13C-labelled 24-residue synthetic peptide ([13C2]CAPLB29ÿ52), corresponding to
the membrane-spanning sequence of phospholamban (PLB), were examined using 13C cross-polarisation magic-angle
spinning (CP-MAS) NMR spectroscopy. CP-MAS spectra of [13C2]CAPLB29ÿ52 reconstituted into unsaturated lipid
membranes indicated that the peptide was mobile at temperatures down to 350‡C. The NMR spectra showed that peptide
motion became constrained in the presence of the SERCA1 isoform of Ca2-ATPase, and chemical cross-linking experiments
indicated that [13C2]CAPLB29ÿ52 and Ca2-ATPase came into close contact with one another. These results together
suggested that the peptide and the 110-kDa calcium pump were interacting in the membrane. Rotational resonance CP-MAS
13C^13C distance measurements on [13C2]CAPLB29ÿ52 reconstituted into lipid bilayers confirmed that the sequence spanning
Phe-32 and Ala-36 was K-helical, and that this structure was not disrupted by interaction with Ca2-ATPase. These results
support the finding that the transmembrane domain of PLB is partially responsible for regulation of Ca2 transport through
interactions with cardiac muscle Ca2-ATPase in the lipid bilayer, and also demonstrate the feasibility of performing
structural measurements on PLB peptides when bound to their physiological target. ß 2000 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Phospholamban (PLB), a 52-residue membrane-
spanning protein located almost exclusively in the
sarcoplasmic reticulum (SR) of cardiac muscle, is
the major target for phosphorylation by cAMP-de-
pendent and calcium/calmodulin-dependent protein
kinases in response to L-adrenergic stimulation [1].
PLB readily self-associates in lipid bilayers to form
a 30-kDa homopentamer, which has been shown to
function as a Ca2 channel in reconstituted lipid bi-
layers [2]. The primary physiological role of PLB,
however, is to regulate the active transport of calci-
um ions into the SR lumen through what is probably
an inhibitory association of monomeric PLB with the
SERCA2 isoform of Ca2-ATPase [3^5], which is
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reversed after phosphorylation of PLB at Ser-16 and
Thr-17 [6,7].
Two structural domains of PLB have been pro-
posed (Fig. 1). The ¢rst domain is a hydrophilic N-
terminal sequence (residues 1^30) that extends from
the membrane into the cytosol and contains the
phosphorylation sites. Solution NMR data of
PLB1ÿ36 has shown that it consists of two predom-
inantly K-helical stretches connected by a turn (resi-
dues Ile-18, Glu-19, Met-20 and Pro-21) that lies
adjacent to the two phosphorylation sites [8]. The
hydrophobic C-terminal sequence (residues 31^52)
spanning the membrane bilayer constitutes the sec-
ond domain. Studies of the membrane-spanning do-
main reconstituted into lipid bilayers, by circular di-
chroism [9] and Fourier transform infrared (FTIR)
spectroscopy [10], both indicate a high degree of K-
helical content, but are unable to de¢ne precise re-
gions of K-helical structure.
The highest (2.6 Aî ) resolution structure of skeletal
muscle Ca2-ATPase to date [11] has failed to shed
light on possible sites of interaction with PLB, and
the mechanism of Ca2-ATPase regulation remains
unclear. Site-directed mutagenesis and functional
studies have shown that the inhibitory association
of PLB with Ca2-ATPase involves interactions
with PLB not only in the cytoplasmic domain
[12^14], but also within the transmembrane region
[12,15]. Although the structure and activity of the
cytoplasmic domain of PLB, and their response
to phosphorylation, have been the subject of a
number of studies, comparatively little is known
about the details, and physiological importance, of
Ca2-ATPase regulation by the PLB membrane
domain.
Here, solid-state NMR was used to investigate the
interaction between the membrane domain of PLB
and Ca2-ATPase in reconstituted lipid bilayers to
gain further insight into the mechanism of Ca2
transport regulation. The high-resolution solid-state
NMR technique of cross-polarisation magic-angle
spinning (CP-MAS) NMR has emerged as a power-
ful tool for determining structural details of integral
membrane proteins and peptides in intact lipid bi-
layers [16,17]. Here, a 23-residue 13C-labelled peptide
corresponding to the C-terminal domain of PLB
([13C2]CAPLB29ÿ52) was incorporated into phospho-
lipid bilayers and its structure and dynamics were
Fig. 1. Schematic diagram of phospholamban (PLB) showing the location of the N-terminal cytoplasmic domain (Ia, Ib) and the C-
terminal membrane domain (II). The peptide [13C2]CAPLB29-52 corresponds to the primary sequence of PLB shown from Asn-29 to
Leu-52, and the expanded chemical structure of residues 32^36 show the sites of 13C isotope labelling at the amide carbonyl of Phe-32
and the K-carbon of Ala-36. The underlined alanine residues were substituted in place of the three native cysteines of phospholamban.
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examined using 13C-CP-MAS NMR. The peptide
was synthesised containing two 13C-enrichment sites
placed four residues apart (Fig. 1), and experiments
were carried out [17^19] to qualitatively examine the
peptide dynamics and to determine its local second-
ary structure in membranes containing the SERCA1
isoform of Ca2-ATPase from rabbit skeletal muscle
sarcoplasmic reticulum.
2. Materials and methods
All reagents were from Sigma and of the highest
grade available unless stated otherwise.
2.1. Peptide synthesis
[13C2]CAPLB29ÿ52 was prepared by solid-phase
peptide synthesis from fmoc-protected amino acids
(Dr. R. Shama and Prof. A. Lee, Southampton Uni-
versity) and puri¢ed by HPLC. The 24-amino acid
peptide contained two 13C-isotope labels at the car-
bonyl of Phe-32 and the CK carbon of Ala-36 (Fig.
1). The three native cysteines were replaced by ala-
nine to reduce the tendency of the peptide to self-
associate [3,20,21] without changing its predicted sec-
ondary structural characteristics [22].
2.2. Characterisation and reconstitution of
[13C2]CAPLB29ÿ52
The oligomeric state of the peptide in 2% SDS was
characterised by SDS^polyacrylamide gel electropho-
resis using a 10^20% gradient Tris-trycine gel. The
gel was stained with SYPRO orange [23] and visual-
ised under UV light at 300 nm.
Incorporation of [13C2]CAPLB29ÿ52 into synthetic
phospholipid membranes was achieved by dissolving
[13C2]CAPLB29ÿ52 (5 mg) with dimyristoylphosphati-
dylcholine (DMPC) or dioleoylphosphatidylcholine
(DOPC) in CHCl3 :CH3OH (5 ml) at a lipid-to-pep-
tide molar ratio of 20:1 and drying to a thin ¢lm
under vacuum. The ¢lm was rehydrated with phos-
phate bu¡er (5 ml, 10 mM KH2PO4, 50 mM NaCl,
pH 7.0), vortexed and brie£y sonicated in a water
bath. The sample was then applied to a continuous
sucrose gradient (5^25% w/w) and centrifuged over-
night (120 000Ug at 4‡C). The peptide-enriched
membrane band was collected (at 20% sucrose con-
centration) and diluted in phosphate bu¡er for cen-
trifugation (200 000Ug, 45 min, 4‡C). The pellet was
stored at 320‡C.
2.3. Puri¢cation and functional characterisation of
Ca2+-ATPase
SERCA1 Ca2-ATPase was prepared from fast-
twitch rabbit skeletal muscle sarcoplasmic reticulum
according to the method of East and Lee [24]. The
protein was characterised by SDS^polyacrylamide
gel electrophoresis. Gels of 5% stacking and 10%
resolving were electrophoresed and stained with Coo-
massie blue. Measurement of Ca2-ATPase hydro-
lytic activity was based on the methods of Hardwicke
and Green [25], in which the rate of p-nitrophenyl
phosphate hydrolysis was followed spectrophotomet-
rically at 400 nm at 37‡C for 5^10 min, using be-
tween 16.14 and 807 Wg of protein.
2.4. Co-reconstitution of [13C2]CAPLB29ÿ52 and
Ca2+-ATPase
Co-reconstitution of [13C2]CAPLB29ÿ52 and Ca2-
ATPase was carried out by dissolving the peptide
(5 mg) and DOPC (28 mg) at a lipid-to-peptide mo-
lar ratio of 20:1, in CHCl3 :CH3OH (5 ml) and dry-
ing to a thin ¢lm under vacuum. The ¢lm was rehy-
drated in phosphate bu¡er (1 ml) containing 12
mg/ml of sodium cholate detergent, which solubilises
the Ca2-ATPase, vortexed and brie£y sonicated in a
water bath. Ca2-ATPase (25 mg) in a small volume
of phosphate bu¡er (25 Wl) was then added to the
peptide suspension at a protein to peptide molar ra-
tio of 1:8, and left for 15 min at room temperature
and for 45 min at 4‡C to equilibrate. After this time,
the detergent was diluted to below its critical micelle
concentration by addition of ice-cold phosphate bu¡-
er and centrifuged (200 000Ug, 45 min, 4‡C). The
resulting pellet was rehomogenised and suspended
in phosphate bu¡er for centrifugation (200 000Ug,
45 min, 4‡C). The pellet was stored at 320‡C.
2.5. Chemical cross-linking
Experiments to cross-link [13C2]CAPLB29ÿ52 to
Ca2-ATPase were carried out using a carbodiimide
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coupling reagent 1-ethyl-3-(3-dimethylaminopropyl)
(EDAC) [26]. A sample of co-reconstituted peptide
and Ca2-ATPase in membranes was resuspended in
phosphate bu¡er (1 ml) and the pH adjusted to 5.0
with HCl (0.1 M). EDAC was added with stirring to
molar excess (5 mg) and left for 60 min on ice. The
pH was then adjusted to pH 7.0 with NaOH (0.1 M)
and allowed to continue stirring for 60 min on ice
and then for a further 60 min at room temperature.
The sample was then centrifuged (200 000Ug, 45
min, 4‡C) to a pellet.
2.6. Circular dichroism spectroscopy
Three samples were prepared for CD spectros-
copy (alongside peptide-free samples): (1) [13C2]-
CAPLB29ÿ52 (100 Wg) solubilised in 2% SDS (in
phosphate bu¡er) to a ¢nal peptide concentration
of 3 WM; (2) [13C2]CAPLB29ÿ52 (160 Wg) reconsti-
tuted in DMPC (1.98 mg) at a lipid-to-peptide molar
ratio of 50:1, to a ¢nal peptide concentration of 29
WM in phosphate bu¡er; and (3) [13C2]CAPLB29ÿ52
reconstituted in DMPC and resolubilised in L-octyl-
glucoside (10 mM, in phosphate bu¡er) to a ¢nal
peptide concentration of 15 WM.
CD measurements were carried out on a JASCO
J720 spectropolarimeter. All spectra were recorded at
room temperature over a wavelength of 195 to 250
nm. The path length of the quartz cell was 1 mm. All
spectra were corrected by subtracting the peptide free
sample. Results are expressed in terms of ellipticity in
units of deg cm2 dmol31.
2.7. NMR spectroscopy
All 13C-MAS NMR spectra were acquired on a
modi¢ed Bruker AMX360WB spectrometer at a
magnetic ¢eld of 8.3 T, using a standard Bruker
double-resonance 4-mm magic-angle spinning probe
tuned to the 13C and 1H Larmor frequencies. For
low temperature experiments, the pre-dried bearing
gas was passed through a heat exchanger immersed
in liquid nitrogen before connection to the probe.
Samples were packed into zirconia rotors ¢tted
with boron nitride caps and rotated at the magic-
angle at spinning frequencies (gr/2Z) of up to
11 000 Hz.
Magnetisation exchange experiments were carried
out at the n = 1 (gr/2Z= 10950 Hz) and n = 2 (gr/2Z=
5545 Hz) rotational resonance condition. Hartmann^
Hahn cross-polarisation (CP) from 1H to 13C was
achieved at a nutation frequency of 60 kHz over a
dipolar contact time of 1.6 ms, immediately followed
by a 13C-£ip-back 90‡ pulse (4 Ws). The peptide 13CK-
spins were selectively inverted using a DANTE pulse
train and detected after incremented mixing intervals
(0.1^60 ms) that allow exchange of Zeeman order
between the two 13C-spins. 13C-Magnetisation was
returned to the transverse plane by applying another
non-selective 4-Ws 90‡ pulse, and the signal was dig-
itally sampled into 1 K complex data points. Protons
were decoupled at a ¢eld of 83 kHz from immedi-
ately after CP until each transient had been collected
[27]. The sample spinning speed was kept constant
(within 5 Hz) and the temperature maintained at
350‡C. FIDs were Fourier transformed into 4K of




Methods were used to prepare phospholipid bi-
layers containing a homogeneous distribution of
[13C2]CAPLB29ÿ52 and Ca2-ATPase. The hydropho-
bic peptide was readily incorporated into DOPC and
DMPC bilayers after co-dissolution (lipid-to-peptide
molar ratio of 20:1) in organic solvents. Puri¢cation
was carried out by density gradient centrifugation of
the membranes, which gave a single narrow band
that sedimented separately from lipid-only disper-
sions. SDS^polyacrylamide gel electrophoresis of
peptide-containing membranes exhibited a single
band under £uorescent light after SYPRO Orange
staining, corresponding to a molecular weight range
of 2^5 kDa (densitometric scans of the gels are
shown Fig. 2). Protein staining was absent from
higher molecular weight regions of the gel sug-
gesting that the three Cys^Ala substitutions pre-
vented the peptide from self-associating in SDS
micelles. The monomeric state of the peptide was
anticipated from the results of previous site-directed
mutagenesis studies [3,20,21], but recent evidence
for oligomerisation of a similar peptide sequence
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to [13C2]CAPLB29ÿ52 has been found independently
by gel electrophoresis [28].
[13C2]CAPLB29ÿ52 was co-reconstituted with Ca2-
ATPase from cholate detergent into DOPC mem-
branes to a ¢nal peptide-to-protein molar ratio of
8:1 and a peptide to lipid molar ratio of 1:20. The
maximal hydrolytic activity (Vmax) of Ca2-ATPase
was 19.1 Wmol/mg/min in the native SR preparation,
but fell to 6.0 Wmol/mg/min in pure DOPC mem-
branes, and lower still to 2.4 Wmol/mg/min in mem-
branes containing the peptide (Table 1). It is known
that reconstitution of Ca2-ATPase using cholate de-
tergent results in a partial loss of ATP hydrolysis
[29^30], but the further loss of activity seen in the
presence of [13C2]CAPLB29ÿ52 con£icts with the re-
sults of previous work showing that the transmem-
brane domain of PLB reduces only the a⁄nity of
Ca2-ATPase for Ca2 without a¡ecting the rate of
ATP hydrolysis [12]. SDS^PAGE gels of the mem-
brane exhibited major bands from Ca2-ATPase and
[13C2]CAPLB29ÿ52 centred approximately at 110 and
3 kDa, respectively, as well as a small number of less
prominent peaks corresponding to protein impurities
in the SR membrane preparation (Fig. 2).
Chemical cross-linking studies formed the basis for
the initial hypothesis that the physiological role of
PLB involves direct interaction of its cytoplasmic
domain with Ca2-ATPase [7]. Here, the chemical
cross-linking agent EDAC was used to determine
whether [13C2]CAPLB29ÿ52 and Ca2-ATPase could
come into close enough contact with each other in
the membrane to support an inhibitory interaction
[12,15]. EDAC links a primary amine to a carboxyl
group (and to a lesser extent, cysteine sulfhydryl and
tyrosine aryl hydroxyl groups) through a short spac-
Fig. 2. Densitometric scans of SYPRO Orange-stained SDS^
PAGE gels (10^20% polyacrylamide gradient) of [13C2]-
CAPLB29ÿ52 in DOPC membranes. Samples contained lipid,
peptide and Ca2-ATPase in a molar ratio of 160:8:1 (A) or
lipid and peptide only, in a molar ratio of 20:1 (B). Membrane
samples were solubilised in SDS and electrophoresed without
boiling (A and B, top scans), or ¢rst incubated for 3 h with the
cross-linking reagent EDAC (A and B, bottom scans).
Table 1
Summary of the structural and functional data obtained for [13C2]CAPLB29ÿ52 (lipid-to-peptide molar ratio of 20:1) and rabbit skele-
tal muscle Ca2-ATPase in lipid bilayers and native membranes
Protein sample Lipid membrane Vmax (Wmol/mg/min) F32INFA36 distance (Aî )a
n = 1 n = 2
[13C2]CAPLC29ÿ52 DMPC ^ 4.3 þ 0.3 4.9 þ 0.9
[13C2]CAPLB29ÿ52+Ca2-ATPaseb DOPC 2.40 5.3 þ 0.3 5.2 þ 0.8
DOPC (cross-linked) 0.05 ^ 5.2 þ 1.7
Ca2-ATPase Native 19.1 ^ ^
DOPC 6.00 ^ ^
aDistance measurements (13CK^13CO) were carried out at n = 1 and n = 2 rotational resonance.
bThe peptide-to-protein molar ratio was 8:1.
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ing sequence, provided the reactive side-groups lie
adjacent to each other. The N-terminally acetylated
[13C2]CAPLB29ÿ52 has a single free carboxyl group at
the C-terminus, but no primary amines, and there-
fore cannot couple to other peptide molecules in the
membrane. Hence, the peptide C-terminus presents a
unique site in [13C2]CAPLB29ÿ52 for reaction with
EDAC, whereas Ca2-ATPase has a preponderance
of lysine O-amino groups with the potential for cross-
linking to the peptide.
Densitometric scans of SDS^PAGE gels of pep-
tide-containing membranes after incubation with
EDAC for 3 h are shown in Fig. 2. Gels of
[13C2]CAPLB29ÿ52 membranes exhibited a single dif-
fuse band of similar intensity and molecular weight
range before and after incubation with EDAC, but
when the peptide was co-reconstituted with Ca2-
ATPase and incubated with EDAC the 110 and
3 kDa bands disappeared from the SDS^PAGE gel.
Since [13C2]CAPLB29ÿ52 is unable to cross-link to
itself, it was assumed that all of the peptide had
coupled to Ca2-ATPase to form high molecular
weight conjugates that are unable to enter the gel.
Hydrolytic activity of Ca2-ATPase was lost almost
entirely after cross-linking with the peptide (Table 1).
3.2. Dynamics of reconstituted [13C2]CAPLB29ÿ52
It was possible to rule out the existence of a sep-
arate fraction of peptide-containing membranes from
which Ca2-ATPase was excluded, because all of the
peptide was able to cross-link to Ca2-ATPase. More
crucially, the results indicated that the peptide and
Ca2-ATPase were able to interact closely with each
other in the membrane. It was not known, however,
if the lifetime of the interaction was long enough to
be physiologically important, or whether the proteins
were coupled together by EDAC simply because of
random molecular collisions resulting from lateral
di¡usion in the membrane.
NMR experiments were carried out to examine
more closely the nature of the interaction between
Ca2-ATPase and [13C2]CAPLB29ÿ52, by qualitative
investigation of peptide dynamics. Membrane pep-
tides can undergo several modes of motion, including
rotational di¡usion and lateral di¡usion within the
plane of the bilayer, with rates depending on the
membrane environment [31,32]. The rates of peptide
rotational and lateral di¡usion are generally highest
for small peptides sequences in £uid lipid bilayers,
but can be reduced considerably in the event of con-
straining interactions with other proteins or interac-
tions between extramembranous regions of the pep-
tide and the lipid headgroups. Hence, a study of the
dynamics of the peptide in reconstituted membranes
might provide some information on the equilibrium
state of the molecular interactions taking place be-
tween [13C2]CAPLB29ÿ52 and Ca2-ATPase.
The 13C-NMR signal intensity from membrane
proteins and peptides under CP-MAS conditions
has been found to diminish in the presence of mo-
lecular motion [33]. Peptide dynamics may give rise
to slow rates of cross-polarisation from 1H to 13C,
shorter T1b relaxation times or interference with pro-
ton decoupling, each of which can lead to a reduc-
tion in signal intensity. Hence, it is usually desirable
to freeze out peptide motions in order to maximise
signal intensity [17]. Here, however, the potentially
destructive e¡ects of molecular dynamics on the CP-
MAS spectrum were used to qualitatively assess the
comparative dynamics of [13C2]CAPLB29ÿ52 in di¡er-
ent environments and in the presence of Ca2-ATP-
ase.
Proton-decoupled 13C-CP-MAS NMR experi-
ments were performed on the peptide incorporated
into DMPC and DOPC bilayers with and without
Ca2-ATPase. Peaks from Ala-36 (13CK) at 54 ppm
and Phe-32 (13CO) at 177 ppm are clearly visible in
spectra of the reconstituted peptide (Fig. 3). The
13CK-resonance of [13C2]CAPLB29ÿ52 is complicated
by the fact that it has a similar chemical shift to the
natural abundance öCH3 resonance from the cho-
line lipid head group (V54ppm). To avoid interfer-
ence from the choline signal, the peptide was there-
fore reconstituted into headgroup-deuterated lipids
for all quantitative NMR experiments. The choline
resonance is not observed in 13C CP-MAS NMR
spectra of d9-DOPC and d9-DMPC because of
the absence of local protons to transfer polarisa-
tion to the methyl carbon nuclei. Spectra of [13C2]-
CAPLB29ÿ52 co-reconstituted into DOPC bilayers
with Ca2-ATPase contained additional contribu-
tions from the natural abundance resonances of the
protein, but the two peptide resonances at 54 and
177 ppm remained clearly visible and provided
an essential peptide signature that enabled [13C2]-
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CAPLB29ÿ52 to be observed in the mixed protein
bilayer (Fig. 3).
Spectra of the peptide in the di¡erent membrane
preparations were recorded over temperatures rang-
ing from 310 to 360‡C. Peptide signal intensity pro-
¢les over the temperature range were plotted from
the integrals of the peptide carbonyl peak at 177
ppm. In all cases, the peptide peak intensities dimin-
ished as the temperature was raised from 360 to
310‡C, probably because of increasing mobility of
the peptides as the membranes grew more £uid at
higher temperatures (Fig. 4). Fully membrane-em-
bedded peptides such as gramicidin also show rapid
rotational di¡usion in £uid membranes [34] while
peptides with hydrophilic sequences extending be-
yond the lipid bilayer, such as the M13 coat-protein,
are motionally restrained even in £uid lipid mem-
branes (Dr. C. Glaubitz, personal communication).
The peaks from the peptide in pure DOPC bilayers
disappeared at temperatures of 320‡C and above,
while a rather less pronounced decline in intensity
was observed from peptide when incorporated into
DMPC bilayers (Fig. 4). Unsaturated and saturated
lipid bilayers di¡er quite markedly in £uidity over
the experimental temperature range; pure DOPC
undergoes chain melting at about 322‡C while
DMPC remains well ordered throughout (DMPC
phase transition +23‡C). Hence, it is expected that
the mobility of the peptide would be rather more
constrained in the DMPC bilayers than in the more
£uid DOPC bilayers, and the CP-MAS intensity pro-
¢les are consistent with this prediction. When
[13C2]CAPLB29ÿ52 was incorporated into DOPC
membranes containing Ca2-ATPase, the decline in
signal intensity was unlike that of the peptide in pure
DOPC bilayers, but instead was rather similar to
that from the peptide in DMPC membranes (Fig.
4). This ¢nding suggests that the mobility of the pep-
tide becomes more constrained in DOPC membranes
when Ca2-ATPase is also present. Such motional
constraints are unlikely to arise from the self-associ-
ation of [13C2]CAPLB29ÿ52, since this would be ex-
6
Fig. 3. Proton decoupled 13C-CP-MAS NMR spectra of mem-
branes containing [13C2]CAPLB29ÿ52, Ca2-ATPase or both.
The protein and peptide were reconstituted into headgroup-deu-
terated d9-DOPC membranes (A^D) in a lipid-to-peptide molar
ratio of 20:1 and spectra were obtained from the following
peptide-to-protein molar ratios: (A) [13C2]CAPLB29ÿ52 only;
(B) [13C2]CAPLB29ÿ52 with polarisation inversion; (C) [13C2]-
CAPLB29ÿ52 and Ca2-ATPase at a 20:1 molar ratio;
(D) [13C2]CAPLB29ÿ52 and Ca2-ATPase at an 8:1 molar ratio;
(E) Ca2-ATPase in native SR membranes. Reconstituted sam-
ples contained 5 mg of peptide, and SR membrane samples
contained 10 mg protein. In the polarisation inversion spec-
trum, the resonances from the lipid hydrocarbon CH2 groups
have negative intensity, the CH resonances from peptide K-car-
bons are suppressed and resonances from the DOPC headgroup
(arrowed) and hydrocarbon terminal CH3 groups remain posi-
tive. The MAS frequency was 5 kHz in all experiments.
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pected to occur with equal probability in the absence
of Ca2-ATPase, and it is more probable that it is
interactions of the peptide with the much larger cal-
cium pump that are responsible for the reduced pep-
tide mobility.
Hence, the cross-linking experiments indicated that
the protein and peptide are able to come into close
contact, and NMR indicated that the lifetime of the
interaction was long on the NMR time-scale.
3.3. Conformational studies of CAPLB29ÿ52 using
circular dichroism
Circular dichroism (CD) was used to examine the
secondary structural content of [13C2]CAPLB29ÿ52 in
a membrane-simulating environment. Spectra indi-
cated that the peptide adopts a mostly K-helical con-
formation in an aqueous solution of 2% SDS, as
characterised by the presence of the large minimum
in the CD spectrum at 208 nm and 222 nm (Fig. 5).
The spectrum of [13C2]CAPLB29ÿ52 reconstituted in
DMPC at a lipid-to-peptide molar ratio of 50:1 also
shows minima at 208 and 222 nm, signifying a K-
helical structure in the presence of lipid. Solubilised
complexes of the DMPC membranes containing
[13C2]CAPLB29ÿ52 with L-octylglucoside (0.34 M),
produced a CD signal comparable to that observed
with [13C2]CAPLB29ÿ52 in 2% SDS. The secondary
structure of the peptide in the presence of Ca2-
ATPase could not be examined because of the over-
whelming contribution from the ion-pump to the
spectrum, which could not be deconvoluted from
the relatively minor component from the peptide.
Quanti¢cation of individual secondary structural
contributions to the spectra was not made because
interpretation of CD spectra of membrane proteins
may not be straightforward owing to the presence of
artefacts arising from scattering e¡ects [35,36]. Qual-
itative analysis of the spectrum by visual inspection
shows the peptide exists largely in a K-helical confor-
mation in the environments examined, as observed
for other similar peptide fragments of PLB [20].
Fig. 5. Circular dichroic spectra of [13C2]CAPLB29ÿ52. Spectra
are shown for the peptide solubilised in 2% SDS (solid line), in-
corporated in DMPC membranes to a lipid-to-peptide ratio of
50:1 (dotted line) and resolubilised from the membranes in
L-octyl glucoside (dashed line). Spectra are shown in elipticity
units (U1033 deg cm2 dmol31).
Fig. 4. The temperature dependence of 13C-CP-MAS NMR
spectra of [13C2]CAPLB29ÿ52 in lipid membranes containing
DOPC, DMPC and DOPC with Ca2-ATPase. The data points
show the integral of the carbonyl resonance from 13C-labelled
Phe-32 over a temperature range of 50‡C. The lipid-to-peptide
molar ratio was 20:1, and the peptide-to-protein molar ratio
was 8:1.
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3.4. Structure of reconstituted [13C2]CAPLB29ÿ52
using NMR
The CD spectra agreed with previous studies [9]
and indicated that the transmembrane domain of
PLB adopts a largely K-helical structure in detergent
micelles and phospholipid membranes, but gave no
impression of which regions of the peptide, if any,
are helical and which are not. Moreover, CD is un-
able to provide qualitative indications of the peptide
secondary structure in the presence of Ca2-ATPase
because of interference from the protein. CP-MAS
NMR was therefore used to examine the secondary
structure in the transmembrane domain in greater
detail, and also to examine how, if at all, the struc-
ture is a¡ected by the presence of Ca2-ATPase.
Rotational resonance, a method based on CP-
MAS NMR, was used to con¢rm the local secondary
structure of [13C2]CAPLB29ÿ52 over a region span-
ning ¢ve residues (Phe-32^Ile-33^Asn-34^Phe-35^
Ala36) putatively lying close to the membrane^water
interface, by measuring the through-space distance
between the 13C sites placed four residues apart
(Fig. 1). Distances are determined in the rotational
resonance experiment by measuring weak homonu-
clear dipole couplings (between 13C and 13C, for ex-
ample), which are introduced when the sample spin-
ning frequency (Xr) is equal to (or is a sub-multiple
of) the frequency separating the isotropic chemical
shifts (vXIS) of the nuclei [27]. Under rotational res-
onance, an experiment is performed to measure the
rate of magnetisation exchange between the nuclei by
measuring the signal intensities from the two nuclei
over a series of mixing intervals. The magnetisation
exchange rate is analysed to determine the dipolar
coupling constant, which is inversely proportional
to internuclear distance. Computer modelling of
[13C2]CAPLB29ÿ52 in various secondary structures
showed that the 13C^13C distance was diagnostic of
secondary structure, and ranged from a maximum of
12.0 Aî for a L-strand to a minimum of 5.1 Aî for an
K-helix. For pairs of 13C-labels, measurable magnet-
isation exchange occurs when the nuclei are sepa-
rated by up to 6.5 Aî .
[13C2]CAPLB29ÿ52 was incorporated into pure
DOPC bilayers and into DOPC membranes contain-
ing Ca2-ATPase to a peptide-to-protein molar ratio
of 8:1, and magnetisation exchange experiments were
carried out at ¢rst-order (Xr =vXIS) and second-order
(Xr =vXIS/2) rotational resonance. The temperature
was maintained at 350‡C to reduce the residual rota-
tional di¡usion of the peptide, which might otherwise
average the dipolar couplings measured. The di¡er-
ences in the peak intensities (after subtraction of nat-
ural abundance signal) for Phe-32 (CO) and Ala-36
(CK) were measured at a number of mixing intervals
and plotted in Fig. 6 to show the extent of magnet-
isation exchange at rotational resonance. In all ex-
periments, magnetisation exchange was found to oc-
cur only at rotational resonance and not at sample
spinning frequencies well away from rotational reso-
nance, indicating that magnetisation is exchanged
under the in£uence of 13C^13C coupling
Numerical simulations of the experimental mag-
netisation exchange data [27] were carried out to ob-
tain values of the Phe-32 to Ala-36 13C^13C distances
in the two membrane samples. The rotational reso-
nance magnetisation exchange pro¢le is dependent
not only on the distance-dependent dipole coupling
constant dIS, but also on the relative orientations of
the chemical shielding tensors of the two spins and
on a damping factor, the zero-quantum relaxation
rate 1/TZQ2 [27]. The zero-quantum relaxation time
TZQ2 can have a dominant e¡ect on the exchange
pro¢le and is di⁄cult to determine accurately,
although an estimate can be obtained from the spec-
tral line widths. Owing to these additional determi-
nants of magnetisation decay and the uncertainties in
their measurement, the experimental data was simu-
lated by calculating a series of curves corresponding
to many random combinations of dIS, T
ZQ
2 and the
angles de¢ning the chemical shift tensor orientations.
The upper and lower limits of the 13C^13C interatom-
ic distance were deduced from the computed curves
falling within the upper and lower error limits of the
experimental data (Fig. 6).
The 13C^13C distances measured for [13C2]-
CAPLB29ÿ52 in the di¡erent membrane environments
are summarised in Table 1. The distance ranged from
4.2 to 5.5 Aî in the case of peptide incorporated into
pure DOPC bilayers, and from 4.5 to 5.7 Aî for the
non-cross-linked peptide in membranes containing
Ca2-ATPase. Models of the pentapeptide sequence
in di¡erent secondary structures showed that the dis-
tances predicted for L-sheet (12.0 Aî ) and extended
con¢guration (13.3 Aî ) structures were too long to
BBAMEM 77917 22-9-00
Z. Ahmed et al. / Biochimica et Biophysica Acta 1468 (2000) 187^198 195
give rise to any measurable magnetisation decay and
could be ruled out de¢nitively. In fact, the distances
determined by rotational resonance were consistent
only with an K-helical structure across the pentapep-
tide region both when [13C2]CAPLB29ÿ52 is incorpo-
rated in pure lipid bilayers and when the peptide
interacts with the membrane-exposed surface of
Ca2-ATPase. Distance measurements also suggested
that the pentapeptide region retained its K-helical
structure after cross-linking of the peptide to Ca2-
ATPase (Table 1).
4. Discussion
The peptide [13C2]CAPLB29ÿ52, which corresponds
to the assumed monomeric [3,20,21] transmembrane
domain of phospholamban, was here found to be K-
helical in a pentapeptide region expected to lie close
to the membrane^water interface. CD spectra of the
peptide in detergent micelles provide evidence that
much of transmembrane peptide is K-helical, which
was also the ¢nding of CD studies on similar peptide
sequences [9]. Some uncertainty exists as to where in
the transmembrane domain the helical structure is
broken, and this work has reduced this uncertainty
by pinpointing, for the ¢rst time, and with some
certainty, a region of the peptide that is K-helical.
NMR and cross-linking studies indicate that an
interaction takes place between reconstituted mono-
meric [13C2]CAPLB29ÿ52 and Ca2-ATPase in the
membrane, which does not involve disruption of
the peptide’s helical structure in the region examined
(Table 1). It is known that the interaction of the
transmembrane domain of PLB with the cardiac
(SERCA2a) isoform of Ca2-ATPase impedes pro-
tein function [15], but the structural features relating
the molecular interaction to the inhibitory e¡ect are
Fig. 6. Plots of magnetisation exchange (¢lled circles) for [13C2]CAPLB29ÿ52 at n = 1 (top) and n = 2 (bottom) rotational resonance at
a constant temperature of 350‡C. Data was obtained for [13C2]CAPLB29ÿ52 when reconstituted into pure DMPC bilayers (left graphs)
to a lipid-to-peptide molar ratio of 20:1, and when co-reconstituted with Ca2-ATPase in DOPC bilayers (right graphs) to a lipid-to-
peptide-to-protein ratio of 20:8:1. The error bars represent the signal-to-noise ratio in the spectra. Curves representing the upper-limit
(dashed line), lower-limit (dotted line) and best-¢t (solid line) to the experimental data were calculated as described in Section 3.4, and
corresponded to the interatomic distances stated on each graph.
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not clear. Our results show that the Vmax of Ca2-
ATPase hydrolytic activity is reduced in the presence
of [13C2]CAPLB29ÿ52, while others have found that
similar peptide fragments of PLB reduce only the
a⁄nity of the enzyme for calcium ions [12,15]. Since
single mutations have been shown to alter the oligo-
meric state of PLB [3,37], it is also conceivable that
subtle di¡erences in the primary sequence of PLB in
the membrane domain, such as the three Cys^Ala
substitutions in [13C2]CAPLB29ÿ52, can cause the hy-
drolytic activity of Ca2-ATPase to be reduced [15]
without a¡ecting the a⁄nity of the enzyme for cal-
cium.
Cross-linking and mutagenesis studies have identi-
¢ed a peptide sequence in the acylphosphorylation
region of Ca2-ATPase that may form the inhibitory
site of interaction with the cytoplasmic domain of
PLB [14]. Although water-soluble peptides corre-
sponding to the cytoplasmic domain of PLB have
shown some inhibitory activity against Ca2-ATPase
[12], full regulation of the calcium pump can only
occur when the transmembrane region of PLB is
also present [38,39]. Here, EDAC cross-linking
(Fig. 2) and variable temperature CP-MAS NMR
spectra (Fig. 4) suggest that the K-helical transmem-
brane region of PLB binds to Ca2-ATPase even at a
peptide concentration that is 8-fold higher than that
of the protein.
The high level of binding of [13C2]CAPLB29ÿ52 to
Ca2-ATPase raises questions about the speci¢city of
the interaction compared with the proposed 1:1 in-
teraction between full-length PLB and Ca2-ATPase.
Non-speci¢c interactions between the hydrophobic
transmembrane domain of PLB and Ca2-ATPase
may be minimised by the size of the 28-residue cyto-
plasmic domain, while no such steric barrier is
present in [13C2]CAPLB29ÿ52. Nevertheless, it is likely
that strong interactions within the membrane do oc-
cur between full-length PLB and Ca2-ATPase, and
a model for the regulatory function of PLB should
therefore take account of the balance between strong
hydrophobic interactions within the membrane and
electrostatic forces in the cytoplasm. Phosphoryla-
tion of PLB has been shown by £uorescence and
NMR spectroscopy to be coupled to a conformation-
al change in the cytoplasmic domain [40,41], and
there is some evidence that the structural change in
phosphorylated PLB may cause the monomers to
dissociate from their inhibitory site and reform pen-
tamers [42,43]. It is possible that conformational
changes occurring after phosporylation of PLB cre-
ate repulsive forces in the cytoplasm that counter the
forces of attraction in the membrane.
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